Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
1.535 USD | -0.97% | +22.80% | -26.90% |
Business Summary
Number of employees: 224
Sales per Business
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Pharma Tests and Services
43.4
%
| 30 | 45.4 % | 32 | 43.4 % | +7.96% |
Enterprise
43.2
%
| 27 | 41.0 % | 32 | 43.2 % | +19.10% |
Population Sequencing
12.8
%
| 8 | 13.0 % | 9 | 12.8 % | +11.48% |
Other
0.6
%
| 0 | 0.6 % | 0 | 0.6 % | +6.08% |
Sales per region
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
United States
90.0
%
| 59 | 91.0 % | 66 | 90.0 % | +11.72% |
International
10.0
%
| 6 | 9.0 % | 7 | 10.0 % | +25.52% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Christopher Hall
CEO | Chief Executive Officer | 55 | 22-10-30 |
Aaron Tachibana
DFI | Director of Finance/CFO | 63 | 19-02-28 |
Richard Chen
CTO | Chief Tech/Sci/R&D Officer | 53 | 11-10-31 |
Caroline Corner
IRC | Investor Relations Contact | - | - |
General Counsel | - | 23-10-17 | |
James Azzaro
SAM | Sales & Marketing | - | 22-04-20 |
Sales & Marketing | - | - | |
John Lyle
PRN | Corporate Officer/Principal | - | 20-07-15 |
Susan Moriconi
HRO | Human Resources Officer | - | 20-12-31 |
Corporate Officer/Principal | - | 11-12-31 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Arthur Bowman
BRD | Director/Board Member | 77 | 19-04-30 |
Kenneth Widder
BRD | Director/Board Member | 71 | 23-06-13 |
Woodrow Myers
BRD | Director/Board Member | 70 | 21-03-05 |
Christopher Hall
CEO | Chief Executive Officer | 55 | 22-10-30 |
Lonnie Shoff
BRD | Director/Board Member | 65 | 22-07-31 |
Karin Eastham
CHM | Chairman | 74 | 19-09-08 |
Olivia Bloom
BRD | Director/Board Member | 55 | 22-02-28 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 51,209,828 | 50,791,176 ( 99.18 %) | 0 | 99.18 % |
Company contact information
Sector
Sales per Business
Sales per region
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-26.90% | 79.38M | |
+19.16% | 42.68B | |
+0.11% | 42.4B | |
+46.06% | 40.04B | |
-6.20% | 28.31B | |
+6.00% | 24.94B | |
-21.79% | 18.96B | |
+29.45% | 12.3B | |
-2.39% | 11.95B | |
-4.90% | 11.55B |
- Stock Market
- Equities
- PSNL Stock
- Company Personalis, Inc.